Correlation of D dimer and factor VIII levels with histopathology in patients with breast carcinoma

Cancer Biomarkers

Volumn 7, Issue 6, 2010, Pages 305-314

  Khangarot, Shyamveer Singh ^a   Gupta, Nikhil ^b   Goswami, Binita ^c   Hadke, Niladhar Shankarrao ^a   Lal, Pawanindra ^a   Gupta, Naresh ^a   Khurana, Nita ^a  

^a MAULANA AZAD MEDICAL COLLEGE   (India)

^b LADY HARDINGE MEDICAL COLLEGE   (India)

^c G B PANT HOSPITAL   (India)

Author keywords

breast cancer; chemotherapy; coagulation; D dimer; Factor VIII

Indexed keywords

BLOOD CLOTTING FACTOR 8; D DIMER; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ADIPOSE TISSUE; ADULT; AGED; ANGIOGENESIS; ARTICLE; BREAST CARCINOMA; CANCER CHEMOTHERAPY; CANCER CLASSIFICATION; CANCER PATIENT; COMPARATIVE STUDY; CONTROLLED STUDY; FALSE NEGATIVE RESULT; FEMALE; FIBRINOLYSIS; GENETIC CORRELATION; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE; LYMPH VESSEL; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN INTERACTION; THORAX RADIOGRAPHY; TUMOR GROWTH; TUMOR VOLUME; VASCULAR TISSUE;

ADULT; AGED; BREAST NEOPLASMS; FACTOR VIII; FEMALE; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; HUMANS; MIDDLE AGED; PROSPECTIVE STUDIES; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 79959700157     PISSN: 15740153     EISSN: 18758592     Source Type: Journal    
DOI: 10.3233/CBM-2010-0196     Document Type: Article

References (30)

1. R.T. Greenlee, T. Murray, S. Bolden and P.A. Wingo, Cancer statistics, CA Cancer J Clin 50 (2000), 7-33.
2. Consolidated Report of the Population Based Cancer Registries Incidence and Distribution of Cancer: 1990-96. New Delhi: ICMR, 2001.
3. W.L. Donegan, Prognostic factors: Stage and receptor status in breast cancer, Cancer 70 (1992), 1755-1764.
4. A.M. Neville, R. Bettelheim and R.D. Gelber, Factors predicting treatment responsiveness and prognosis in node-negative breast cancer. The International (Ludwig) Breast Cancer Study Group, J Clin Oncol 10 (1992), 696-705.
5. T. Hasebe, K. Mukai and H. Tsuda, New prognostic histological parameter of invasive ductal carcinoma of the breast: clinicopathological significance of fibrotic focus, Pathol Int 50 (2000), 263-272. (Pubitemid 30441277)
6. K. Axelsson, B.M. Ljung and D.H.Moore, Tumor angiogenesis as a prognostic assay for invasive ductal breast carcinoma, J Natl Cancer Inst 87 (1995), 997-1008.
7. R. Seshadri, D.J. Horsfall and F. Firgaira, The relative prognostic significance of total cathepsin D and HER-2/neu oncogene amplification in breast cancer: The South Australian Breast Cancer Study Group, Int J Cancer 56 (1994), 61-65.
8. M.J.Duffy,D. Reilly andD.McDermott, Urokinase plasminogen activator as a prognostic marker in different subgroups of patients with breast cancer, Cancer 74 (1994), 2276-2280. (Pubitemid 24322282)
9. L. Pusztai, M. Ayers and F.W. Simmans, Emerging science: prospective validation of gene-expression profilin-based prediction of complete pathologic response to neoadjuvant paclitaxel/ FAC chemotherapy in breast cancer, Proc Am Soc Clin Oncol 22 (2003), 1.
10. G. Buccheri, D. Ferrigno, C. Ginardi and C. Zuliani, Haemostatic abnormalities in lung cancer: prognostic implications, Eur J Cancer 33 (1997), 50-55. (Pubitemid 27099567)
11. E.M. van Duijnhoven, F.A. Lustermans and J.W. van Wersch, Evaluation of the coagulation/fibrinolysis balance in patients with colorectal cancer, Haemostasis 23 (1993), 168-172. (Pubitemid 23308551)
12. M.Z. Wojtukiewicz, E. Sierko, P. Klement and P. Rak, The hemostatic system and angiogenesis in malignancy, Neoplasia 3 (2001), 371-384. (Pubitemid 32988807)
13. M.Z.Wojtukiewicz, E. Sierko and E. Rak, Contribution of the hemostatic system to angiogenesis in cancer, Semin Thromb- Hemost 30 (2004), 5-20. (Pubitemid 38457297)
14. L.H. Iversen and L.H. Thorlacius-Ussing, Systemic coagulation reactivation in recurrence of colorectal cancer, Thromb Haemost 89 (2003), 726-734. (Pubitemid 36456970)
15. J.H. Beer, A. Haeberli and A. Vogt, Coagulation markers predict survival in cancer patients, Thromb Haemost 88 (2002), 745-749. (Pubitemid 35345330)
16. T. Akashi, Y. Furuya, S. Ohta and S. Fuse, Tissue factor expression and prognosis in patients with metastatic prostate cancer, Urology 62 (2003), 1078-1082. (Pubitemid 37510095)
17. C.G. Mitter and C.C. Zielinski, Plasma levels of D-dimer: A crosslinked fibrin-degradation product in female breast cancer, J Cancer Res Clin Oncol 117 (1991), 259-262.
18. V. Abbasciano, D. Tassinari and D. Sartori, Usefulness of coagulationmarkers in staging of gastric cancer, CancerDetect Prev 19 (1995), 331-336.
19. Y. Engin, G. Guzin, Y. Idris, Trugut, D. Erdem and B. Ç akar, Relation between hemostatic parameters and prognostic/ predictive factors in breast cancer, Eu J of Int Med (2007), 1-6.
20. W.P. Mielicki,M. Tenderenda, P.Rutkowski andK.Chojnowski, Activation of blood coagulation and the activity of cancer procoagulant (EC 3.4.22.26) in breast cancer patients, Cancer Lett 146 (1999), 61-66. (Pubitemid 29462557)
21. M.F. Loreto, M. De Martinis, M.P. Corsi, M. Modesti and L. Ginaldi, Coagulation and Cancer: Implications for Diagnosis and Management, Pathol Oncol Res 6(4) (2000), 301-312. (Pubitemid 32167627)
22. R. Seitz, N. Rappe andN.Kraus, Activation of coagulation and fibrinolysis in patients with lung cancer: relation to tumour stage and prognosis, Blood Coagul Fibrinolysis 4 (1993), 249-254. (Pubitemid 23103801)
23. L.Y. Dirix, R. Salgado, R. Weytjens, C. Colpaert, I. Benoy, P. Huget et al., Plasma fibrin D-dimer levels correlate with tumour volume, progression rate and survival in patients with metastatic breast cancer, Br J Cancer 86 (2002), 389-395. (Pubitemid 34185123)
24. W.P. Mielicki, M. Tenderenda, P. Rutkowski and P. Chojnowski, Activation of blood coagulation and the activity of cancer procoagulant (EC 3.4.22.26) in breast cancer patients, Cancer Lett 146 (1999), 61-66. (Pubitemid 29462557)
25. E. Yigit, G. Guzin, Y. Idris, Trugut, D. Erdem and B. Ç akar, Relation between hemostatic parameters and prognostic/ predictive factors in breast cancer, Eu J of Int Med (2007), 1-6.
26. K. Blackwell, Z. Haroon, G. Broadwater, D. Berry, L. Harris, J.D. lglehart et al., Plasma D-dimer levels in operable breast cancer patients correlate with clinical stage and axillary lymph node status, J Clin Oncol 18 (2000), 600-608. (Pubitemid 30078541)
27. M.Z. Khan, M.S. Khan, F. Raziq and A.M. Khattak, Fibrinogen degradation products and D-dimers in patients with breast carcinoma, Gomal J of Med Sci 5 (2007), 9-12.
28. M. Bébenek, D. Dús and J.Kózlak, Fas expression in primary breast cancer is related to neoplastic infiltration of perilymphatic fat, Adv in Med Sci 53(1) (2008), 49-53.
29. D. Petrovic, Effect of CMF-chemotherapy on blood coagulation in patients with breast cancer, Archive of Oncology 10(2) (2002), 61-66.
30. C.C. Kirwan, G. McDowell, C.N. McCollum, S. Kumar and G.J. Byrne, Early changes in the haemostatic and procoagulant systems after chemotherapy for breast cancer, Br J Cancer 99 (2008), 1000-1006.